Progesterone secretion after LH-antisera or ergocryptine treatment of normal or hysterectomized pseudopregnant rats.
D004092:20-alpha-Dihydroprogesterone / Q000378:metabolism; D000818:Animals; D003338:Corpus Luteum / Q000502:physiology; D003340:Corpus Luteum Maintenance / Q000187:drug effects; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D007044:Hysterectomy; D007106:Immune Sera / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism; D011555:Pseudopregnancy / Q000187:drug effects*; D051381:Rats
D004873:Ergolines; D007106:Immune Sera; D004092:20-alpha-Dihydroprogesterone; D011374:Progesterone; D011388:Prolactin; D007986:Luteinizing Hormone